Learn More
Medchemexpress LLC Pulrodemstat (benzenesulfonate) | 2097523-60-7 | 99.6% | 1 ML

Supplier: Medchemexpress LLC HY129388B10MM/1ML
Pulrodemstat benzenesulfonate is a potent, selective, reversible, and orally active inhibitor of lysine specific demethylase-1 (LSD1), with an IC50 of 0.25 nM. It demonstrates less enzymatic inhibition against LSD2, MAO-A, and MAO-B. This compound induces differentiation in acute myeloid leukemia (AML) and small cell lung cancer (SCLC) cells, exhibiting potent anticancer activity.
- Potent, selective, reversible, and orally active LSD1 inhibitor (IC50 0.25 nM)
- Induces differentiation in acute myeloid leukemia (AML) and small cell lung cancer (SCLC) cells
- Exhibits potent anticancer activity
- Shows antiproliferative activity in AML kasumi-1 cells (EC50 2 nM)
- Inhibits tumor growth in patient-derived xenograft SCLC models
- Downregulates GRP mRNA levels
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.